Skip to main content
Klarovel

Evidence-based peptide writing

Research-backed articles on peptides, protocols, and longevity science.

Every post on this blog is built around a single rule: the load-bearing claim has to point at a peer-reviewed source. The catalog spans five clusters: the GH-axis (CJC-1295, ipamorelin, tesamorelin, MK-677), the GLP-1 class (semaglutide, tirzepatide, retatrutide, cagrilintide), tissue healing (BPC-157, TB-500, GHK-Cu, KPV), cognitive peptides (semax, selank, dihexa), and longevity (NAD+, epitalon, DSIP, thymosin alpha-1). Pieces are reviewed against PubMed, ClinicalTrials.gov, FDA, EMA, Helsedirektoratet, FHI, and Legemiddelverket. We hedge claims the literature hedges and we name the gaps where the human-trial database is still light.

Explore by cluster

  • Growth-hormone axis

    GHRH analogues and GH-releasing peptides for body composition, recovery, and the IGF-1 lever. CJC-1295, ipamorelin, tesamorelin, sermorelin, MK-677, GHRP-2 and GHRP-6.

  • GLP-1 class + metabolic

    Incretin-receptor agonists for weight management and metabolic disease. Semaglutide, tirzepatide, retatrutide, cagrilintide, liraglutide. Class explainers, head-to-head comparisons, and the Norwegian regulatory picture.

  • Tissue healing + recovery

    Peptides studied for tissue repair, gut barrier, and inflammation. BPC-157, TB-500, GHK-Cu, KPV, and the stacking question the research community keeps returning to.

  • Cognitive peptides

    Compounds with evidence for attention, mood, and neuroplasticity. Semax, selank, dihexa, cerebrolysin. Includes the where-the-data-runs-out caveats.

  • Longevity + metabolic

    Compounds in the longevity and metabolic-health corner of the catalog. NAD+, epitalon, DSIP, thymosin alpha-1, plus the regulatory framing each one currently sits in.

Each guide opens with a Key Takeaways box that summarises the load-bearing claims in 3 to 5 bullets. The body always moves mechanism, evidence, dosing, then risk profile. Reviewer date and credentials sit in the byline of every post. If you are new to peptide research, the [What are peptides used for](/blog/what-are-peptides-used-for) and [What is peptide therapy](/blog/what-is-peptide-therapy) posts are the right starting points before the deeper protocol guides.

Split laboratory scene contrasting peptide vials with SARM capsules, illustrating a regulatory and safety comparison.
Safety

Peptides vs SARMs: Safety, Legality, and Mechanism Compared

A research-first comparison of peptides and SARMs across mechanism of action, regulatory status, hepatic risk, and hormonal axis impact for informed readers.

July 22, 2026·8 min read
Amber peptide vials in a laboratory freezer rack at minus twenty degrees Celsius, arranged next to aliquoting tubes and bacteriostatic water.
Protocol

Peptide Storage Guide: Cold Chain, Aliquots, Shelf Life

How to store lyophilized and reconstituted research peptides: freezer temperatures, aliquoting workflow, bacteriostatic water windows, and cold-chain rules.

July 20, 2026·10 min read
Side-by-side illustration of P21 and Semax peptide molecules over a stylised hippocampus cross-section, labelled for a nootropic comparison.
Comparison

P21 vs Semax: which nootropic peptide wins in 2026?

P21 vs Semax head-to-head on mechanism, dosing, and evidence. One is a CNTF-derived neurogenic peptide, the other a Russian-approved BDNF booster.

July 18, 2026·11 min read
Pill organiser next to injection vials on a clinical desk, illustrating the intersection of peptides and prescription medications.
Safety

Peptide Drug Interactions: What Research Actually Shows

Peptide drug interactions remain understudied. Here is what current research suggests about GLP-1 agonists, GH secretagogues, and repair peptides.

July 17, 2026·13 min read
Split editorial illustration comparing hexarelin injection vial with MK-677 oral capsule against a GH pulsatility graph
Comparison

Hexarelin vs MK-677: Ghrelin Mimetics Head-to-Head (2026)

Hexarelin's acute GH spike versus MK-677's oral 24-hour IGF-1 elevation. Which ghrelin-receptor agonist actually fits your research goal, and where each fails.

July 16, 2026·12 min read
Laboratory blood sample tubes arranged on a requisition form beside a peptide protocol tracker, representing baseline monitoring labs.
Safety

Peptide Bloodwork Panel: The Baseline Labs That Matter

A research-grade guide to peptide bloodwork panels: which markers to draw, when to retest, and how to read IGF-1, lipase, and metabolic shifts safely.

July 15, 2026·9 min read
Split-frame illustration of a chromosome telomere cap next to a glowing NAD+ coenzyme molecule, representing two different longevity mechanisms.
Comparison

Epitalon vs NAD+: Which Longevity Path Fits You (2026)

Epitalon activates telomerase on short cycles; NAD+ precursors refill a daily metabolic cofactor. Head-to-head on evidence, dosing, and how to choose.

July 14, 2026·12 min read
Vial of hexarelin research peptide beside a laboratory notebook and reconstitution syringe on a clinical bench
Peptide guide

Hexarelin Peptide: The Forgotten GHRP and Why It Faded

Hexarelin was once the most potent GHRP known. Research suggests tachyphylaxis and CD36 side effects explain why the peptide world moved on.

July 13, 2026·10 min read
Split-frame illustration comparing BPC-157 tissue repair pathway with thymosin alpha-1 T-cell immune modulation pathway.
Comparison

BPC-157 vs Thymosin Alpha-1: Healing vs Immune Modulation (2026)

BPC-157 targets tissue repair and gut lining; thymosin alpha-1 modulates T-cell immunity. Head-to-head on mechanism, dosing, side effects, and stacking.

July 11, 2026·13 min read
Tesofensine 0.5 mg oral tablets on a research bench next to a body composition report, illustrating the fourth-class weight loss compound.
Peptide guide

Tesofensine: The Fourth-Class Weight Loss Peptide Guide

Tesofensine is a triple monoamine reuptake inhibitor that produced 10.6% weight loss in Phase 2. Mechanism, doses, safety, and GLP-1 comparison.

July 10, 2026·12 min read
Split composition showing MK-677 oral capsules on one side and tesofensine tablets on the other, over a background of a research protocol chart.
Comparison

MK-677 vs Tesofensine: GH Support vs Fat Loss (2026)

MK-677 raises GH and appetite; tesofensine is a central appetite suppressor with 9% weight loss. Head-to-head on mechanism, dose, and evidence.

July 9, 2026·13 min read
Neurologist reviewing a cognitive assessment chart beside a vial of peptide solution in a clinical research setting.
Science

Peptides for Dementia: What the Clinical Evidence Actually Shows

A clinical look at Cerebrolysin, Semax, and Dihexa for dementia. Trial data, real limits, and why the peptide-dementia story needs honest framing.

July 8, 2026·12 min read
Side-by-side comparison of KPV tripeptide and thymosin alpha-1 peptide vials with molecular structure overlays on a laboratory bench.
Comparison

KPV vs Thymosin Alpha-1: Which Wins for Gut and Immune?

KPV calms inflammation in the gut and skin. Thymosin alpha-1 modulates immunity. A head-to-head on mechanism, evidence, and when to pick which.

July 7, 2026·11 min read
Lifter preparing a peptide vial in a home research setting, notebook and calibrated syringe on a clean bench under soft lighting.
Peptide guide

Peptides for Bodybuilding: What the GH-Axis Research Shows

A clinical look at GH-axis peptides used in physique work: what the human trials on MK-677, CJC-1295 and ipamorelin actually document, plus WADA rules.

July 6, 2026·10 min read
Two labeled research vials of ipamorelin and hexarelin on a clinical bench beside a syringe and reconstitution water.
Comparison

Ipamorelin vs Hexarelin: Clean Signal or Raw Potency (2026)

Ipamorelin vs hexarelin, compared on GH pulse size, cortisol impact, cardiac effects, and desensitization. Which GHRP actually fits your protocol.

July 4, 2026·10 min read
Amber vial of reconstituted sermorelin acetate on a clinical bench next to an insulin syringe and a lab notebook with IGF-1 values.
Peptide guide

Sermorelin: A Complete Guide to the GHRH 1-29 Analog

Sermorelin is a 29-amino-acid GHRH analog with a short half-life and long-tail GH effect. Here is what the primary literature actually shows in adults.

July 3, 2026·11 min read
Split laboratory illustration comparing the 7-amino acid TB-500 fragment with the full 43-amino acid thymosin beta-4 parent peptide.
Comparison

TB-500 vs Thymosin Beta-4: Fragment or Full-Length in 2026

TB-500 is a 7-amino acid fragment of thymosin beta-4's actin-binding site. Which one actually has human trial data? A head-to-head breakdown.

July 2, 2026·14 min read
Neuron network illustration with highlighted synaptic connections representing peptide effects on attention and cognitive focus.
Science

Peptides for Focus: What the Cognitive Research Actually Shows

A clinical look at Semax, Selank, and Dihexa: how each peptide works on attention and focus, what studies report, and where the evidence still thins out.

July 1, 2026·11 min read
Side-by-side comparison of MK-677 oral capsule and tesamorelin injection vial representing two routes to the GH-IGF-1 axis.
Comparison

MK-677 vs tesamorelin: oral GH versus visceral fat (2026)

Head-to-head on MK-677 vs tesamorelin: oral ghrelin mimetic versus injectable GHRH analogue, with VAT data, glucose risk, and a clear decision rule.

June 30, 2026·13 min read
Glass vial of research peptide on a clean clinical bench beside a neural-pathway diagram, soft blue lighting, editorial science photography.
Science

Peptides for Anxiety: What the Research Actually Shows

A clinical-grade review of peptides studied for anxiety, including Selank, Semax, and oxytocin, with evidence, mechanisms, and realistic expectations.

June 29, 2026·11 min read
Side-by-side laboratory comparison of Dihexa oral capsules and Semax intranasal solution with neuron synapse illustration in background.
Comparison

Dihexa vs Semax: which nootropic peptide wins in 2026?

Dihexa drives HGF-c-Met synaptogenesis; Semax upregulates BDNF and NGF. Compare mechanism, dosing, evidence and safety to choose the right tool.

June 27, 2026·12 min read
Line chart visualisation of a GLP-1 weight loss curve flattening around week 60, with annotations marking the plateau region.
Science

GLP-1 Weight Loss Plateau: Why It Happens and What Works

GLP-1 plateaus arrive near week 60 in most trials. Here is the physiology, what the STEP and SURMOUNT data actually show, and how to respond intelligently.

June 24, 2026·10 min read
Conceptual illustration of cellular mitochondria with a warm amber NAD+ molecular accent, representing peptide approaches to longevity biology.
Peptide guide

Peptides for Longevity: the 2026 Evidence Map

A pillar guide to peptides studied for longevity: NAD+, MOTS-c, Epitalon, SS-31. Mechanisms, evidence quality, and where the human data still sits in 2026.

June 23, 2026·12 min read
Two labeled vials of GHRH analog peptides on a clinical bench, representing the sermorelin and tesamorelin head-to-head comparison.
Comparison

Sermorelin vs Tesamorelin: Which GHRH Analog Wins in 2026?

Sermorelin vs tesamorelin compared on mechanism, half-life, dosing, and trial data. The deciding factor: visceral fat targeting versus general GH support.

June 23, 2026·13 min read
Amber glass ampoule of Cerebrolysin neuropeptide solution on a clinical tray with a syringe and gloved hand in soft laboratory light.
Peptide guide

Cerebrolysin: Complete Guide to the Neuropeptide Mixture

An evidence-based look at Cerebrolysin: porcine-derived neuropeptides, trial data across stroke, dementia and TBI, dosing protocols, and safety signals.

June 22, 2026·11 min read
Side-by-side editorial illustration comparing oral tesofensine capsules and a semaglutide injection pen on a clinical neutral background.
Comparison

Tesofensine vs Semaglutide: Which Wins in 2026?

Tesofensine vs semaglutide, head-to-head: mechanism, dosing, weight loss magnitude, cardiovascular trade-offs, and which compound the trial data actually favors.

June 20, 2026·12 min read
Vials and a comparison chart representing GLP-1, dual agonist, and growth hormone axis peptides studied for fat loss outcomes.
Comparison

Best Peptides for Fat Loss: What the 2026 Evidence Shows

An evidence-led comparison of GLP-1, dual, and triple agonist peptides for fat loss. Trial data, mechanisms, and where lesser-known options actually fit.

June 19, 2026·11 min read
Side-by-side comparison of CJC-1295 and tesamorelin vials with annotated half-life and FDA approval status on a clinical bench.
Comparison

CJC-1295 vs Tesamorelin: GHRH Analogues Head-to-Head (2026)

CJC-1295 vs tesamorelin, two GHRH analogues with very different evidence files. One has FDA approval; the other has an 8-day half-life. Here is the deciding split.

June 18, 2026·12 min read
Researcher studying brain scans on a monitor showing cognitive activity patterns related to post-viral brain fog and neuroinflammation.
Science

Peptides for Brain Fog: What the Long-COVID Research Shows

An evidence-based look at peptides studied for post-viral brain fog: mechanisms, the cognitive peptide candidates, and what the long-COVID data actually says.

June 17, 2026·14 min read
Side-by-side schematic of Cerebrolysin IV vial and Semax intranasal spray illustrating neurotrophic peptide comparison.
Comparison

Cerebrolysin vs Semax: Neurotrophic Showdown (2026)

Cerebrolysin vs Semax compared on mechanism, dosing, evidence quality and side effects. Which Russian-stack peptide actually earns its reputation?

June 16, 2026·13 min read
Stylised illustration of hippocampal neurons forming new dendritic spines, representing dihexa's proposed synaptogenic mechanism.
Peptide guide

Dihexa Peptide: What Research Actually Shows in 2026

Dihexa is an oral, brain-penetrant angiotensin IV analog studied for cognition. Here is what the preclinical evidence supports, and what it does not.

June 15, 2026·11 min read
Split-frame editorial illustration contrasting TB-500 actin filaments with GHK-Cu copper-bound tripeptide molecular structures on a clinical backdrop.
Comparison

TB-500 vs GHK-Cu: which recovery peptide actually wins?

TB-500 mobilises actin and angiogenesis; GHK-Cu rewires copper signalling and collagen. A head-to-head on mechanism, evidence, dosing, and the right call by goal.

June 13, 2026·11 min read
Illustration of a mitochondrion releasing the 16 amino acid MOTS-c peptide into the cytoplasm of a skeletal muscle cell.
Peptide guide

MOTS-c Peptide: Complete Guide to the Mitochondrial Mitokine

A research-based guide to MOTS-c, the mitochondrial-derived peptide studied as an exercise mimetic for metabolic health, AMPK signaling, and longevity.

June 12, 2026·13 min read
Side-by-side vials of ipamorelin and tesamorelin with a research notebook, illustrating GHRP versus GHRH peptide comparison for the GH axis.
Comparison

Ipamorelin vs Tesamorelin: GHRP vs GHRH Compared (2026)

Ipamorelin vs tesamorelin compared: GHRP selectivity against FDA-approved GHRH visceral-fat data, dosing, side effects, and which fits your goal.

June 11, 2026·13 min read
Vial of human chorionic gonadotropin alongside a subcutaneous syringe on a clinical surface, illustrating hCG protocols studied in men.
Peptide guide

HCG for Men: Fertility, TRT and Testicular Function Guide

How hCG works in men, what the evidence shows for fertility, testicular size and hypogonadism, and how researchers think about dose, timing and safety.

June 10, 2026·13 min read
Two labelled vials side by side on a clinical surface representing cagrilintide and retatrutide phase 2 weight-loss comparison.
Comparison

Cagrilintide vs Retatrutide: Weight Loss Head-to-Head 2026

Cagrilintide vs retatrutide compared: trial efficacy, dosing, tolerability, and the decision rule for picking between an amylin analogue and a triple agonist.

June 9, 2026·13 min read
Clinical research notebook beside a vial of reconstituted DSIP peptide on a dim bedside table at night, ready for a documented sleep study.
Peptide guide

DSIP Peptide and Sleep: What the Evidence Actually Shows

DSIP peptide sleep claims sit on decades of mixed human data. Klarovel reviews the mechanism, dose ranges, regulatory status, and protocol guardrails.

June 8, 2026·13 min read
FDA building exterior in Silver Spring, Maryland, representing US federal peptide regulation under the 503A and 503B compounding framework.
Safety

Are Peptides Legal in the US? FDA & DEA Status in 2026

The legal status of peptides in the US is layered, fast-moving, and easy to misread. Here is what FDA, DEA, and the 503A/503B framework actually say in 2026.

June 6, 2026·14 min read
Side-by-side schematic of CJC-1295 and sermorelin molecules with GHRH receptor binding, half-life timelines, and weekly vs nightly dosing cadence.
Comparison

CJC-1295 vs Sermorelin: the GHRH Head-to-Head Comparison

CJC-1295 vs sermorelin compared on half-life, dosing cadence, published human data, and side-effect profile. Daily vs weekly, with citations.

June 6, 2026·12 min read
Side-by-side molecular structures of BPC-157 pentadecapeptide and KPV tripeptide on a clinical research backdrop.
Comparison

BPC-157 vs KPV: gut-healing peptide head-to-head (2026)

BPC-157 vs KPV compared on mechanism, oral stability, colitis evidence, and side effects. The deciding factor: where in the gut the inflammation actually sits.

June 4, 2026·16 min read
Researcher reviewing brain imaging data on a monitor next to a notebook of ADHD attention assessment scales in a quiet lab.
Science

Peptides for ADHD: What Semax Research Actually Shows

Best peptide for ADHD focus? An honest look at Semax, Selank, and BDNF mechanisms, plus what the preclinical and pilot data actually support in 2026.

June 3, 2026·13 min read
Side-by-side vials of AOD-9604 and tirzepatide on a clinical bench with syringe and dose chart.
Comparison

AOD-9604 vs Tirzepatide: Targeted vs Systemic (2026)

AOD-9604 vs tirzepatide compared head-to-head: mechanism, dose ranges, side-effect ledger, and which the published trials actually back for fat loss.

June 2, 2026·15 min read
Stylised illustration of the inner mitochondrial membrane with cristae folds and cardiolipin molecules, the binding target of SS-31 peptide.
Peptide guide

SS-31 Peptide: The Mitochondrial Longevity Angle Explained

SS-31 (elamipretide) targets cardiolipin to restore mitochondrial function. What the FDA approval, clinical trials, and aging research actually show.

June 1, 2026·13 min read
Two labelled research vials of ipamorelin and sermorelin side by side on a clinical bench with a reconstitution syringe.
Comparison

Ipamorelin vs Sermorelin: GH Axis Head-to-Head (2026)

Ipamorelin vs sermorelin compared on mechanism, dosing, evidence, and side effects. Which GH-axis peptide actually fits your goal? Sourced from primary trials.

May 30, 2026·14 min read
Norwegian competitive athlete reviewing the WADA 2026 prohibited list of peptides before a training session
Safety

Peptides on the Doping List: A 2026 WADA Reference

What every Norwegian competitive athlete should know about peptides on the WADA 2026 prohibited list, S0/S2/S4 classifications, and detection windows.

May 29, 2026·15 min read
Two labeled vials representing cagrilintide and tirzepatide on a clean lab surface, illustrating an amylin vs dual incretin comparison.
Comparison

Cagrilintide vs Tirzepatide: Amylin or Dual Incretin?

Cagrilintide targets amylin satiety; tirzepatide hits GIP + GLP-1. A head-to-head on dosing, weight loss, side effects, and which mechanism fits which goal.

May 28, 2026·12 min read
Split scientific illustration comparing a SARM androgen receptor binding model with a peptide signaling cascade on a clinical lab background.
Comparison

SARMs vs Peptides: How the Two Compound Classes Differ

SARMs hit androgen receptors and carry liver and cardiovascular risk; peptides act as targeted signaling molecules. A clinical-grade comparison.

May 28, 2026·11 min read
Editorial line-art of a shield over three abstract peptide-category zones on cream paper with a single copper accent
Safety

Are Peptides Safe? The Honest 2026 Side-Effect Guide

Are peptides safe? An honest 2026 look at side effects, who should avoid them, the sourcing risk picture, and how the law treats them in Norway.

May 26, 2026·15 min read
Editorial line-art of weight-loss dose pens at ascending heights on cream paper with a single copper efficacy-curve accent
Comparison

GLP-1 Weight Loss Medications Compared: 2026 Guide

Tirzepatide, semaglutide, liraglutide and the GLP-1 frontier compared by 2026 trial data: efficacy, side effects, dosing, and the Norway picture.

May 26, 2026·18 min read
Side-by-side composition of a GH secretagogue peptide vial and a testosterone gel sachet on a clinical lab bench for a head-to-head comparison.
Comparison

Peptides vs TRT: GH Secretagogues or Testosterone in 2026

Peptides vs TRT compared head-to-head: mechanism, dosing, side-effect profiles, and a decision rule for choosing between GH stacks and testosterone.

May 26, 2026·14 min read
Conceptual image of neurons forming new synaptic connections, representing BDNF-mediated neuroplasticity studied in peptide research.
Peptide guide

Peptides for Depression: Selank, Semax & the BDNF Case

Evidence-based look at peptides studied for depressive symptoms: Semax and Selank, their BDNF effects, dosing context, and what the science does not yet support.

May 25, 2026·11 min read
Clinical notebook with peptide vials, blood pressure cuff and lab printout showing liver enzymes, used to monitor peptide side effects during a cycle.
Safety

Peptide Side Effects: A Comprehensive Safety Guide 2026

Side effects across BPC-157, semaglutide, tirzepatide, melanotan II, ipamorelin and more. Trial-level adverse event data, monitoring rules, when to stop.

May 24, 2026·12 min read
Side-by-side schematic of cagrilintide binding amylin receptors and semaglutide binding GLP-1 receptors in the brainstem and hypothalamus.
Comparison

Cagrilintide vs Semaglutide: Two Pathways, One Choice

Cagrilintide is an amylin analogue. Semaglutide is a GLP-1 agonist. The REDEFINE trials show the deciding factor is whether you stack them or pick one.

May 23, 2026·14 min read
Dim bedroom at night with a sleep tracker glowing on a bedside table, illustrating peptide protocols for sleep architecture and recovery.
Peptide guide

Peptides for Sleep: DSIP, Selank and Epitalon Compared

How DSIP, Selank and Epitalon target different sleep failures (architecture, anxious wake-ups, melatonin decline) and what the research actually shows.

May 23, 2026·12 min read
Anatomical diagram of subcutaneous injection zones on the abdomen, anterior thigh, posterior upper arm, and deltoid region.
Protocol

Peptide Injection Sites: A Site-by-Site Protocol Guide

A site-by-site review of abdomen, thigh, upper arm, and shoulder for peptide injections, with pharmacokinetic differences and rotation rules that protect tissue.

May 22, 2026·13 min read
Norwegian customs envelope next to a vial labeled GHK-Cu and a regulatory document, illustrating the legal grey zone for copper peptides.
Safety

GHK-Cu Legal Status in Norway: What Researchers Need to Know

GHK-Cu sits between cosmetic ingredient and prescription peptide in Norway. Here is what DMP, customs, and the EU cosmetics framework actually permit in 2026.

May 21, 2026·12 min read
Side-by-side illustration of a recombinant HGH vial and a GH-secretagogue peptide vial on a clinical research bench.
Comparison

Peptides vs HGH: Is This Just Expensive Growth Hormone?

Peptides vs HGH compared on mechanism, dosing, side effects, and US legal status. The deciding factor is not strength, it is regulatory exposure.

May 21, 2026·15 min read
Laboratory vial of lyophilized thymosin alpha-1 next to a syringe and reconstitution diluent on a clean white research bench.
Peptide guide

Thymosin Alpha-1: Complete Guide to the Immune Peptide

Thymosin alpha-1 explained: mechanism, the hepatitis B reference dose, sepsis and COVID-19 trial data, safety profile, and what the research actually shows.

May 20, 2026·12 min read
Side-by-side comparison illustration of BPC-157 pentadecapeptide and GHK-Cu copper tripeptide showing systemic vs topical tissue repair pathways.
Comparison

BPC-157 vs GHK-Cu: which tissue-repair peptide wins in 2026?

BPC-157 vs GHK-Cu compared on mechanism, dosing, evidence and side-effect profile. The deciding factor is which tissue you are actually trying to repair.

May 19, 2026·12 min read
Cyclic heptapeptide structure of PT-141 (bremelanotide) overlaid on a schematic of hypothalamic melanocortin receptor binding sites.
Peptide guide

PT-141 Guide: Mechanism, Evidence, and Honest Limits

PT-141 (bremelanotide) acts on brain melanocortin receptors, not blood vessels. What the FDA approval, RECONNECT trials, and side-effect data actually show.

May 19, 2026·14 min read
Two labelled vials representing AOD-9604 and semaglutide on a clinical surface beside a measuring tape and notebook with trial data.
Comparison

AOD-9604 vs semaglutide: lipolysis vs satiety (2026)

AOD-9604 vs semaglutide head-to-head: GH-fragment lipolysis against GLP-1 satiety. Trial data, dosing, side effects, and a clear decision rule.

May 18, 2026·13 min read
Adult performing a barbell back squat in a home gym, illustrating resistance training as a strategy for muscle preservation on GLP-1 therapy.
Science

GLP-1 Muscle Loss: What the Data Actually Shows in 2026

GLP-1 muscle loss is real but manageable. Trial data, mechanisms, and a protein-plus-resistance protocol to preserve lean mass during semaglutide or tirzepatide.

May 18, 2026·14 min read
Flat-lay of a research-grade subcutaneous injection setup: insulin syringe, alcohol swab, sharps container, and a site-rotation chart.
Protocol

Peptide Injection Technique: A Research Skills Primer

How to think about peptide injection technique: site selection, angle, needle gauge, rotation, and sterility. A research-grade primer for protocol literacy.

May 18, 2026·11 min read
Map of weight-loss medications approved in Norway in 2026 with pen injectors and oral tablets arranged on a clinical surface.
Comparison

Weight-Loss Medication in Norway 2026: The Complete Map

Every approved obesity medicine in Norway in 2026, plus the research-only frontier. Wegovy, Mounjaro, Saxenda, Ozempic, Mysimba, retatrutide.

May 18, 2026·17 min read
Side-by-side comparison of liraglutide daily injection pen and semaglutide weekly injection pen on a clinical background.
Comparison

Liraglutide vs Semaglutide: which GLP-1 wins on weight loss?

Head-to-head on Saxenda vs Wegovy: dosing, weight loss, cardiovascular data, and tolerability. STEP 8 and SELECT settle most of the argument.

May 16, 2026·11 min read
Two semaglutide injection pens side by side on a neutral clinical surface, illustrating the Ozempic versus Wegovy comparison.
Comparison

Ozempic vs Wegovy: What Actually Separates Them in 2026

Same molecule, different label. A clinical breakdown of Ozempic and Wegovy: dose ceilings, approved uses, Norwegian reimbursement reality, and trial data.

May 16, 2026·15 min read
Clinical vial of CagriSema combination injection alongside REDEFINE trial chart showing weight reduction across 68 weeks.
Comparison

CagriSema vs Semaglutide: Inside Novo Nordisk's Combo Bet

CagriSema pairs semaglutide with cagrilintide and hit 22.7% weight loss in REDEFINE 1. Here is what the phase 3 data actually shows, side by side.

May 15, 2026·13 min read
Side-by-side editorial illustration of an ipamorelin subcutaneous injection vial and an oral MK-677 capsule on a clinical surface.
Comparison

Ipamorelin vs MK-677: Pulsatile or Sustained GH (2026)

Injectable ipamorelin vs oral MK-677: pulsatile pulses versus 24-hour elevation. Half-lives, dosing, side effects, and a clear decision rule.

May 14, 2026·12 min read
Wegovy FlexTouch pen on a clinical white surface beside a weekly dose tracker, illustrating the 16-week titration schedule.
Peptide guide

Wegovy in Norway: A Complete Guide to Semaglutide 2.4 mg

Wegovy dosing, side effects, pricing in Norway, and STEP/SELECT trial outcomes for semaglutide 2.4 mg. A research-grade guide for adults considering treatment.

May 14, 2026·14 min read
Vial of unlicensed Melanotan 2 nasal spray seized at a Norwegian customs checkpoint, illustrating the regulatory status of the peptide.
Safety

Melanotan 2 in Norway: Law, Risks, and Safer Tan Options

What research shows about Melanotan 2, why DMP has not approved it in Norway, the documented melanoma case reports, and evidence-based pigmentation alternatives.

May 13, 2026·13 min read
Diagram of the hypothalamic-pituitary GH axis showing GHRH, ghrelin, somatostatin, pituitary somatotrophs, and hepatic IGF-1 output.
Science

The GH peptide axis: how GHRH, ghrelin, and IGF-1 connect

A pillar guide to the GH peptide axis: how GHRH analogs and ghrelin mimetics drive pulsatile growth hormone, and what somatopause actually changes after 40.

May 12, 2026·12 min read
Editorial illustration of the cagrilintide amylin analog peptide structure with a once-weekly subcutaneous injection pen on a clinical surface.
Peptide guide

Cagrilintide Complete Guide: Amylin Analog for Weight Loss

Cagrilintide is the long-acting amylin analog behind CagriSema. Mechanism, REDEFINE 1 data, dosing, side effects, and comparison to semaglutide, in plain English.

May 11, 2026·15 min read
Side-by-side molecular illustration of ipamorelin pentapeptide and CJC-1295 GHRH analog with growth hormone pulse curves
Comparison

Ipamorelin vs CJC-1295: GHRP vs GHRH Head-to-Head (2026)

Ipamorelin vs CJC-1295 settled: one is a ghrelin-receptor pulse, the other a GHRH analog with a six-day half-life. Here is which to pick, and when.

May 11, 2026·13 min read
Laboratory vials and a molecular model representing therapeutic peptides used in research and clinical settings
Peptide guide

What Are Peptides Used For? An Evidence-Based Primer

A clear, research-grounded look at what peptides are used for in 2026: from approved indications like diabetes and obesity to recovery research.

May 10, 2026·13 min read
Microscope view of fibroblasts migrating across a wound bed during peptide-supported tissue repair research.
Peptide guide

Peptides for Healing: Research-Backed Tissue Repair Guide

How peptides for healing actually work. Mechanisms, evidence, and protocol logic for BPC-157, TB-500, GHK-Cu, and KPV across tendon, skin, and gut.

May 9, 2026·16 min read
Laboratory vial labelled AOD-9604 next to molecular structure diagram of the 16-amino-acid hGH fragment
Peptide guide

AOD-9604 peptide: the fat-metabolism fragment guide

AOD-9604 is a 16-amino-acid growth hormone fragment studied for fat metabolism. What the trials actually showed, what they did not, and where it fits today.

May 8, 2026·13 min read
Editorial line-art of a single insulin syringe on cream, copper meniscus on the barrel, fine 31 gauge needle visible at the right edge
Protocol

How to inject peptides: technique, sites, rotation

How to inject peptides subcutaneously in 2026. Insulin syringe choice, four primary sites, rotation discipline, the 5-10 second hold, and the Norway frame.

May 7, 2026·18 min read
Editorial line-art of three peptide categories on cream: approved medicines, compounded grey zone, research-only, with copper regulatory accent
Science

What is peptide therapy? Three categories that matter

Peptide therapy means three different things in 2026: FDA-approved medicines, compounded peptides in a reopened grey zone, and research-only peptides.

May 5, 2026·19 min read
Editorial line-art rendering of a three-residue peptide ribbon on a cream background with one warm tan accent residue, suggesting KPV
Peptide guide

KPV peptide guide: what the preclinical research shows

KPV is the three-amino-acid fragment of alpha-MSH. Preclinical data points to NF-kB suppression, gut and skin effects, but human trials remain absent.

April 28, 2026·16 min read
Editorial line-art of the GH and IGF-1 axis from hypothalamus to pituitary to skeletal muscle, off-white with warm amber accent
Peptide guide

Peptides for Muscle Growth: What the 2026 Data Says

Trials report 1.1 to 1.3 kg lean mass gain on growth-hormone peptides over 6 to 12 months. The data and what it does not show, plus WADA status.

April 28, 2026·18 min read
Editorial line-art illustration of three weight-loss dose pens stacked on off-white paper with a warm amber dose curve accent
Peptide guide

Peptides for Weight Loss: What the 2026 Trial Data Says

Four peptide medications are FDA-approved for weight loss in 2026. Trial data, mechanism, side effects, and how the approved options compare.

April 28, 2026·19 min read
Editorial macro of muted indigo neural filaments with a warm tan accent, suggesting calm allosteric modulation without human anatomy
Peptide guide

Selank Peptide: Russian-Approved, Not FDA-Authorized

Selank peptide is a Russian-approved anxiolytic that modulates GABA-A and enkephalins. The mechanism, the 62-patient trial, and 2026 regulatory reality.

April 25, 2026·17 min read
Editorial macro illustration of dendritic neural filaments in deep navy and warm gold, suggesting neurotrophic signaling without any human anatomy
Peptide guide

Semax Peptide: Approved in Russia, Unscheduled in the US

Semax peptide is a Russian-approved nootropic that raises BDNF and shows neuroprotective effects after stroke. The science and the 2026 regulatory reality.

April 25, 2026·16 min read
Abstract editorial composition of a sealed parcel with a warm amber customs-stopped indicator on off-white paper, architectural drafting aesthetic
Safety

Are peptides legal in Norway? The 2026 regulatory answer

Peptides in Norway are mostly unlawful to import privately. What DMP stops at customs, what's approved on prescription, and how Norwegian law handles the rest.

April 24, 2026·17 min read
Abstract editorial illustration of a neuron synapse with peptide molecules crossing the gap, soft clinical palette with warm amber receptor accent
Peptide guide

Cognitive peptides: promise, evidence, and a retraction

Research-first walkthrough of cognitive peptides, what Semax, Selank, and DSIP actually do, which claims don't hold up, and what to watch in 2026.

April 22, 2026·25 min read
Abstract molecular lattice with warm amber benzyl-alcohol accents on off-white paper, editorial line-art, architectural style
Protocol

Bacteriostatic water: why it matters and how much to use

Bacteriostatic water is the 0.9% benzyl-alcohol diluent that keeps reconstituted peptides stable for 28 days. Here's the chemistry, the volumes, and the math.

April 20, 2026·9 min read
Scientific illustration of tendon collagen fibers with amber capillary branches growing through the tissue, warm off-white backdrop, editorial style
Peptide guide

BPC-157 peptide: mechanism, evidence, and protocol guide

BPC-157 is the most-searched healing peptide. Here's the mechanism, the preclinical evidence, the limited human data, and how to think about the protocol.

April 20, 2026·12 min read
Abstract illustration of tendon collagen fibers interwoven with actin filaments, amber and sage accents, editorial line-art
Protocol

BPC-157 + TB-500 stack: what the evidence actually says

The BPC-157 + TB-500 stack is the most common healing peptide protocol. Here's the mechanism rationale, the dosing framework, and what the evidence supports.

April 20, 2026·12 min read
Split-frame illustration with tendon collagen and amber capillaries on left, actin cytoskeleton and sage polymerization on right, editorial line-art
Comparison

BPC-157 vs TB-500: when to use each for tissue repair

BPC-157 and TB-500 are the two most-researched tissue-repair peptides. Different mechanisms, different use cases. Here's how to decide between them.

April 20, 2026·10 min read
Abstract illustration of the hypothalamic-pituitary axis with two converging amber and sage signaling arrows on off-white paper, editorial line-art
Peptide guide

CJC-1295 + Ipamorelin: the GH stack mechanism explained

The CJC-1295 + Ipamorelin stack pairs a GHRH analogue with a GHRP for amplified GH pulses. Mechanism, dose pattern, and what the research shows.

April 20, 2026·10 min read
Abstract illustration of a chromosome with amber telomere end-caps and subtle sage pineal silhouette, editorial line-art on off-white paper
Peptide guide

Epitalon peptide: the longevity tetrapeptide explained

Epitalon is a tetrapeptide associated with telomerase activity and pineal-gland regulation. Here's what the research actually shows, and where the evidence is thin.

April 20, 2026·9 min read
Abstract illustration of a copper-chelation complex with a central amber ion bound by a tripeptide coordination, sage green bonds, editorial line-art
Peptide guide

GHK-Cu copper peptide: skin and hair research review

GHK-Cu is the fastest-growing peptide in search volume. The copper complex is a real biological signal, but the hype outruns the clinical data. The real picture.

April 20, 2026·11 min read
Abstract line-art of three molecular receptor structures with warm amber accent on a muted off-white backdrop
Science

GLP-1 class: semaglutide, tirzepatide, retatrutide compared

Semaglutide, tirzepatide, and retatrutide share a pharmacology family but each activates different metabolic receptors. Here's what the difference actually means.

April 20, 2026·11 min read
Line-art of sterile liquid flowing into a glass vial with an amber meniscus accent on off-white paper, architectural editorial style
Protocol

How to reconstitute peptides: a complete step-by-step guide

Peptide reconstitution is the step most people get wrong. Bacteriostatic water, sterile technique, dose math, storage, here's the evidence-based walkthrough.

April 20, 2026·10 min read
Abstract illustration of a compact peptide ribbon folded into a selective-binding conformation with amber binding pocket, editorial line-art
Peptide guide

Ipamorelin: the cleanest GHRP in the research catalogue

Ipamorelin is the most selective ghrelin mimetic in the GHRP class, with no meaningful cortisol or prolactin lift. Mechanism, dose framework, and evidence.

April 20, 2026·9 min read
Illustration of an orally active small-molecule structure with elongated amber half-life accent, editorial line-art
Peptide guide

MK-677 (ibutamoren): the oral GH secretagogue explained

MK-677 (ibutamoren) is the only orally active growth hormone secretagogue. Mechanism, half-life, dosing pattern, and the side-effect trade-offs that matter.

April 20, 2026·7 min read
Abstract illustration of a NAD molecular ring structure with a warm amber adenine region and subtle sage mitochondrial silhouette, editorial line-art
Peptide guide

NAD+ therapy: injection mechanism, evidence, and dosing

NAD+ is the coenzyme powering cellular energy metabolism. NAD+ therapy by injection anchors many longevity protocols. What the research shows on mechanism and dose.

April 20, 2026·10 min read
Still-life of a closed leather medical chart beside a sealed amber vial on a warm off-white desk, institutional clinical gravitas
Safety

Who shouldn't take peptides: contraindications guide

Peptides aren't for everyone. Active cancer, pregnancy, uncontrolled diabetes, severe kidney or liver impairment: who should avoid which peptide classes.

April 20, 2026·10 min read
Architectural line-art of a proportional dose ladder on off-white paper with a single warm amber highlighted step, editorial mathematical aesthetic
Protocol

Peptide dosing math: mcg, mg, IU and syringe units

Peptide dose math is simple once you separate the three unit systems. Here's how mcg, mg, and IU relate, and how to read them off an insulin syringe.

April 20, 2026·9 min read
Abstract illustration of three peptide ribbon structures converging toward a central warm amber node, triple-agonist composition on off-white paper
Peptide guide

Retatrutide: What the triple-agonist trials actually show

Retatrutide is the first triple GIP-GLP-1-glucagon agonist. Phase 3 trials show 28.7% weight loss at 68 weeks. Here's what the evidence actually shows.

April 20, 2026·13 min read
Scientific illustration of a long peptide ribbon with a warm amber active region on off-white paper, editorial style
Peptide guide

Semaglutide (Wegovy, Ozempic): complete evidence guide

Semaglutide is the first widely adopted GLP-1 receptor agonist for obesity and type-2 diabetes. Here's how it works, what the trials show, and who it fits.

April 20, 2026·9 min read
Split-frame with a single peptide ribbon on left and two intertwined ribbons on right, amber and sage accents, editorial line-art
Comparison

Semaglutide vs tirzepatide: the real head-to-head comparison

Semaglutide vs tirzepatide: a direct head-to-head trial settled the efficacy question. Tirzepatide won on weight loss. Here's what else the evidence actually shows.

April 20, 2026·10 min read
Abstract illustration of actin cytoskeleton filaments flowing diagonally with amber polymerization accents on off-white paper, editorial line-art
Peptide guide

TB-500 (thymosin beta-4): mechanism and protocol guide

TB-500 is the synthetic thymosin beta-4 fragment used in tissue-repair research. Here's the actin-binding mechanism, the preclinical evidence, and typical protocols.

April 20, 2026·11 min read
Abstract illustration of an elongated GHRH-analog peptide ribbon with a warm amber active-site accent on off-white paper, editorial line-art
Peptide guide

Tesamorelin (Egrifta): the FDA-approved GHRH analogue

Tesamorelin is a stabilised GHRH analogue with FDA approval for HIV-associated lipodystrophy. Here's the mechanism, the dosing, and why it's different from CJC-1295.

April 20, 2026·8 min read
Abstract illustration of two peptide ribbon structures intertwined in a dual-agonist composition on off-white paper, amber and sage green accents
Peptide guide

Tirzepatide (Mounjaro, Zepbound): complete evidence guide

Tirzepatide is the first dual GIP/GLP-1 receptor agonist. Phase 3 trials show 22.5% mean weight loss at 72 weeks. Here's the full breakdown with citations.

April 20, 2026·9 min read

Newsletter

Field notes.

Notes from the engine team. What we learned, what we changed, what the literature actually says. Wednesdays.

One email per week. No tracking pixels. One-click unsubscribe in every issue.